Short-term diabetes decreases ischemia reperfusion-induced arrhythmia: The effect of alpha-2 blocker yohimbine and glibenclamide

Basit Öğe Kaydı
dc.authorid0000-0001-5073-0691
dc.authorid0000-0002-4133-407
dc.authorid0000-0002-9677-8823
dc.contributor.authorBozdoğan, Ömer
dc.contributor.authorKaya, Salih Tunç
dc.contributor.authorYaşar, Selçuk
dc.contributor.authorBaş, Erçin Çağdaş
dc.contributor.authorÖzarslan, Oğulcan Talat
dc.contributor.authorEkşioğlu, Didem
dc.contributor.authorErim, Firdevs
dc.date.accessioned2021-06-23T18:40:11Z
dc.date.available2021-06-23T18:40:11Z
dc.date.issued2016
dc.departmentBAİBÜ, Fen Edebiyat Fakültesi, Biyoloji Bölümüen_US
dc.departmentBAİBÜ, Lisansüstü Eğitim Enstitüsü, Fen Bilimleri, Biyoloji Ana Bilim Dalı
dc.description.abstractThis study examined the effect of yohimbine alone and in combination with glibenclamide on ischemia and reperfusion-induced arrhythmias in diabetes. Six minutes of ischemia were produced in 1-week diabetic rats by ligation of the left coronary artery, and 6 min of reperfusion were produced by releasing the artery. A dose of 5 mg/kg of yohimbine and glibenclamide was administered for 7 days prior to the coronary ligation. The blood pressure, heart rate, and arrhythmia were determined from the recorded ECG during the 6 min of ischemia and reperfusion and then compared using a one-way ANOVA statistical program and the chi-square test. The score of arrhythmia calculated from the type and duration of arrhythmia decreased in the diabetic rats (3.5 ± 1.69 in control, 1.7 ± 0.81 in diabetes group). The arrhythmia score returned to the control value in the rats that were given a combination of yohimbine and glibenclamide (3 ± 1.73). Yohimbine is used in the treatment of erectile dysfunction; glibenclamide is used as an antidiabetic drug in diabetic patients and may be a risk factor in the increase of ischemia reperfusion-induced arrhythmias.en_US
dc.identifier.endpage905en_US
dc.identifier.issn1300-0152
dc.identifier.issn1303-6092
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-84975296088en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage899en_US
dc.identifier.trdizinid214743en_US
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TWpFME56UXpNdz09
dc.identifier.urihttps://hdl.handle.net/20.500.12491/3001
dc.identifier.volume40en_US
dc.identifier.wosWOS:000378689600019en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.institutionauthorBozdoğan, Ömer
dc.institutionauthorYaşar, Selçuk
dc.institutionauthorBaş, Erçin Çağdaş
dc.institutionauthorÖzarslan, Oğulcan Talat
dc.institutionauthorEkşioğlu, Didem
dc.institutionauthorErim, Firdevs
dc.language.isootheren_US
dc.relation.ispartofTurkish Journal of Biologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectIschemiaen_US
dc.subjectReperfusion
dc.subjectArrhythmia
dc.subjectDiabetes
dc.subjectGlibenclamide
dc.subjectYohimbine
dc.titleShort-term diabetes decreases ischemia reperfusion-induced arrhythmia: The effect of alpha-2 blocker yohimbine and glibenclamideen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
omer-bozdogan.pdf
Boyut:
371.7 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin / Full text
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu
Biyoloji Bölümü Koleksiyonu
Fen Bilimleri Enstitüsü/Diğer Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu